Ranitidine was added in various concentrations (25-1600 ng/ml) to clonal assays of haemopoietic progenitors of normal human peripheral blood or bone marrow. Although a significant reduction in colonies forming from granulocyte-macrophage progenitors (CFU-GM) was demonstrated at the lowest drug concentration, no significant growth suppression was seen at higher concentrations. There was no evidence for growth inhibition of either erythroid progenitors (BFU-E) or pluripotent progenitors (CFU-mix) at any of the drug concentrations studied. A direct toxic effect of ranitidine on normal haemopoietic progenitors thus appears an unlikely cause of cytopenias observed during treatment.
Get full access to this article
View all access options for this article.
References
1.
de Galossy C. & de Strihou C.Pancytopenia with cimetidine . Annals of Internal Medicine1979; 90: 274.
2.
Gross S. & Worthington-White D.Cimetidine suppression of CFU-C in males. American Journal Haematology1984; 17: 279-86.
3.
Fitchen JH & Koeffler HPCimetidine and granulopoiesis: bone marrow culture studies in normal man and patients with cimetidine associated neutropenia. British Journal of Haematology1980; 46: 361-6.
4.
Byron JWBone marrow toxicity of metiamide. Lancet1976; ii: 1350.
5.
Zeldis J., Friedman L. & Isselbacher K.Ranitidine: a new H2-receptor antagonist. New England Journal of Medicine1983; 309: 1368-73.
6.
Spychal RT & Wickham Nwr.Thrombocytopenia associated with ranitidine. British Medical Journal1985; 291: 1687.
7.
Amos RJ, Kirk B., Amess Jal, Jones AL & Hinds CJBone marrow hypoplasia during intensive care: bone marrow culture implicating ranitidine in the suppression of haemopoiesis. Human Toxicology1987; 6: 503-6.
8.
Herrera A., Solal-Celigny P., Dresch C., Vallin J. & Bernades P. Ranitidine .New England Journal of Medicine1984; 310: 1604.
9.
Harman DC & Shuman R. Ranitidine .New England Journal of Medicine1984; 310: 1604.
10.
Shields L., Files J., Doll D. & Greenberg B. Ranitidine and agranulocytosis. Annals of Internal Medicine1986; 104: 128.
11.
Brenner L. Ranitidine and agranulocytosis. Annals of Internal Medicine1986; 104: 896.
12.
Aglietta M. , Stacchini A., Sanario F. & Piacibello W.H2receptor antagonists and human granulopoiesis. Experientia1985 ; 41: 375-6.
13.
Gamelli R., Foster R. & Whisnant J.Haemopoietic toxicity by cimetidine. Transplantation1983; 35: 12-4.
14.
Howell A.Bone marrow cells resistant to chloramphenicol in chloramphenicol induced aplastic anaemia. Lancet1975; i: 65-9.
15.
Steed A., Ellis ME, Lenehan H. & Delamore IWAmodiaquine induced agranulocytosis in suppression of granulopoietic differentiation in vitro by a metabolite but not the parent drug. British Journal of Haematology1986; 64: 836.
16.
Ascensao J., Flynn P., Slungaard A., Wachsman W., Zanjani E. & Jacob H.Quinidine induced neutropenia: report of a case with drug dependent inhibition of granulocyte colony generation. Acta Haematologica1984; 72: 349-54.
17.
Barrett AJ, Weller E., Rozengurst N., Longhurst P. & Humble JGAmidopyrine agranulocytosis: drug inhibition of granulocyte colonies in the presence of patients serum. British Medical Journal1976; ii: 850-1.
18.
Kelton J., Huang A., Mold N., Logue G. & Rosse WFThe use of in vitro techniques to study drug induced pancytopenia . New England Journal of Medicine1979; 301: 621-4.
